Radionuclide therapy for pancreatic neuroendocrine neoplasms / 中国实用外科杂志
Chinese Journal of Practical Surgery
;
(12): 934-938, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-816488
ABSTRACT
Pancreatic neuroendocrine neoplasms(pNENs)are the most common neuroendocrine tumors.For early local pNENs,surgery is the main therapeutic strategy and the tumor can be removed completely.But for those pNENs that cannot be surgically removed or have undergone distant metastasis,peptide receptor radionuclide therapy(PRRT)can be chosen as a first-line therapeutic strategy as pNENs overexpress somatostatin receptors.In recent years,clinical trials and studies on the use of PRRT in pNENs have been increasing rapidly.Many reports have confirmed the efficacy of 90 Y and 177 Lu-labeled somatostatin analogue in pNENs patients.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Practical Surgery
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS